Lazard Asset Management LLC Coherus Bio Sciences, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 883,729 shares of CHRS stock, worth $963,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares

883,729

Previous 630,747 40.11%

Holding current value

$963,264

Previous $1.09 Million 15.77%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.99 - $1.8 $250,452 - $455,367	252,982 Added 40.11%	883,729 $919,000
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $384,014 - $610,047	243,047 Added 62.69%	630,747 $1.09 Million
Q1 2024 May 14, 2024	BUY	$2.02 - $3.14 $756,100 - $1.18 Million	374,307 Added 2794.8%	387,700 $926,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $704,675 - $1.71 Million	-443,192 Reduced 97.07%	13,393 $44,000
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $351,328 - $511,962	-93,938 Reduced 17.06%	456,585 $1.71 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $656,390 - $1.44 Million	173,190 Added 45.9%	550,523 $2.35 Million
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $351,108 - $627,107	59,611 Added 18.76%	377,333 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $891,884 - $1.58 Million	156,746 Added 97.37%	317,722 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $1.1 Million - $2.12 Million	152,754 Added 1857.87%	160,976 $1.55 Million
Q2 2022 Aug 09, 2022	SELL	$5.86 - $13.23 $85,942 - $194,031	-14,666 Reduced 64.08%	8,222 $59,000
Q1 2022 May 13, 2022	SELL	$10.92 - $16.41 $256,467 - $385,405	-23,486 Reduced 50.64%	22,888 $295,000
Q4 2021 Feb 09, 2022	BUY	$15.81 - $18.99 $609,175 - $731,703	38,531 Added 491.28%	46,374 $740,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $182,262 - $255,713	-14,374 Reduced 64.7%	7,843 $126,000
Q2 2021 Aug 12, 2021	SELL	$12.95 - $15.41 $814,024 - $968,657	-62,859 Reduced 73.89%	22,217 $307,000
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $363,081 - $538,578	25,179 Added 42.04%	85,076 $1.24 Million
Q4 2020 Feb 11, 2021	BUY	$16.56 - $18.94 $991,894 - $1.13 Million	59,897 New	59,897 $1.04 Million
Q3 2017 Nov 13, 2017	SELL	$11.1 - $14.5 $545,010 - $711,950	-49,100 Closed	0 $0
Q2 2017 Aug 19, 2019	BUY	N/A	49,100	49,100 $704,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Coherus Bio Sciences, Inc. Transaction History